PrednisoloneMultiple endocrinopathies and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1914卷 / 1期

关键词：

D O I：

10.1007/s40278-022-18959-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：373 / 373

相关论文

共 50 条

[21] AntineoplasticsPseudocirrhosis and lack of efficacy: case report
Reactions Weekly, 2021, 1885 (1) : 75 - 75
[22] DurvalumabColitis and lack of efficacy: case report
Reactions Weekly, 2025, 2056 (1) : 181 - 181
[23] AntineoplasticsNeutropenia and lack of efficacy: case report
Reactions Weekly, 2023, 1959 (1) : 89 - 89
[24] DurvalumabPneumonitis and lack of efficacy: case report
Reactions Weekly, 2023, 1985 (1) : 208 - 208
[25] AntineoplasticsMyelosuppression and lack of efficacy: case report
Reactions Weekly, 2022, 1925 (1) : 66 - 66
[26] AntineoplasticsDiarrhoea and lack of efficacy: case report
Reactions Weekly, 2023, 1966 (1) : 48 - 48
[27] AntifungalsHepatotoxicity and lack of efficacy: case report
Reactions Weekly, 2021, 1886 (1) : 52 - 52
[28] ImmunosuppressantsArteriolopathy and lack of efficacy : case report
Reactions Weekly, 2024, 2019 (1) : 218 - 218
[29] LurasidonePseudothrombocytopenia and lack of efficacy: case report
Reactions Weekly, 2022, 1900 (1) : 201 - 201
[30] AntineoplasticsDiarrhoea and lack of efficacy: case report
Reactions Weekly, 2023, 1979 (1) : 46 - 46

← 1 2 3 4 5 →